BioXcel Therapeutics (BTAI) Q4 2024 Earnings

Nov 14Confirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-8.09
-5.46
-2.84
-0.21

Details

Expected EPS
-8.088685
Actual EPS
-5.12
Surprise EPS
2.97
Surprise Percent
+36.7%

Description

⁨BioXcel Therapeutics⁩ (⁦BTAI⁩) has reported earnings of ⁦-5.12⁩ per share for ⁦Q4 2024⁩.

0 Comments

Share your thoughts